Services de réadaptation des victimes d AVC en milieu hospitalier. Optional Performance Indicator Protocols

Size: px
Start display at page:

Download "Services de réadaptation des victimes d AVC en milieu hospitalier. Optional Performance Indicator Protocols"

Transcription

1 Services de réadaptation des victimes d AVC en milieu hospitalier Optional Performance Indicator Protocols 1

2 2 Services de réadaptation des victimes d AVC en milieu hospitalier

3 Stroke Distinction Optional Performance Indicator Protocols 1. Percentage of patients who receive acute ASA therapy within the first 48 hours of hospital arrival. Purpose and Rationale Acute aspirin therapy reduces the risk of early recurrent ischemic stroke. It also reduces the risk of venous thromboembolism. Definition Numerator: Number of ischemic stroke patients who receive acute aspirin therapy within the first 48 hours of arrival to hospital. Include as an event for the numerator: All ischemic stroke and TIA patients who receive aspirin within the first 48 hours Patients who receive Clopidigrel (Plavix) or Aggrenox in the first 48 hours instead of aspirin Exclude as an event for the numerator: Stroke patients with no documentation that aspirin was given in the first 48 hours Denominator: Total number of ischemic stroke/tia patients seen in the emergency department or admitted to inpatient. Include as an event for the denominator: All ischemic stroke and TIA patients Exclude as an event for the denominator: All subarachnoid and intracerebral hemorrhage patients Collecting Data Start time should be the triage time as a national standard. Stop time should be the time documented on the patient medication record as the time first dose of ASA given. This can be given orally or through an NG tube. Performance Indicator Threshold 90% of all ischemic stroke and TIA patients should receive acute aspirin within 48 hours of triage in the ED 1

4 Analysis and Reporting Report proportion of all ischemic stroke/tia patients who receive acute aspirin therapy within 48 hours Limitations and Considerations May also calculate and be aware of median door to acute aspirin administration time in an effort to improve the quality of this performance measure Patients who receive acute thrombolysis (tpa) may not be given an acute aspirin dose until 24 hours after tpa administration. Patients who receive tpa should not be excluded from the denominator, and should be included in the numerator if they receive aspirin in the first 48 hours. 2

5 2. Proportion of stroke /TIA patients who receive brain CT / MRI within 24 hours Purpose and Rationale All patients with suspected stroke or TIA should undergo brain imaging immediately upon presentation to hospital. It is not possible to differentiate an ischemic stroke from a hemorrhagic stroke based on clinical presentation alone, and therefore brain imaging is required to guide management decisions. Definition Numerator: Number of stroke patients who arrive in an ED and receive their first CT or MRI scan within 24 hours of arrival in ED. Include as an event for the numerator: All ischemic, hemorrhagic and TIA stroke patients who receive either CT or MRI within the first 24 hours of hospital arrival Includes patients admitted to hospital and those discharged directly from the ED Exclude as an event for the numerator: Patients with no documentation of a CT or MRI performed in the first 24 hours form hospital arrival (triage time) Denominator: Total number of stroke patients admitted to ED and/or inpatient care. Include as an event for the denominator: All ischemic, hemorrhagic and TIA stroke patients who present to an acute care hospital and receive a diagnosis of stroke Includes patients admitted to hospital and those discharged directly from the ED Exclude as an event for the denominator: There should be no exclusions from this denominator Collecting Data Time should be calculated from hospital ED triage time to the time the scan is started. Start time of the CT or MRI scan is documented on the scan report. This performance measure is included in CIHI Stroke Special Project 340 to enable standardized and consistent data collection. Performance Indicator Threshold 90% of all stroke/tia patients have a CT or MRI completed within 24 hours of hospital arrival 3

6 Analysis and Reporting Calculate and report count of stroke and TIAs receiving a CT or MRI within the first 24 hours; and as a proportion of all stroke and TIA patients (n, %) Limitations and Considerations Some patients may receive a CT or MRI scan at one hospital and then be transferred to a second hospital, usually with more advanced stroke care capability, for management. These patients should be included in the numerator and denominator of this measure. In some cases, patients may be first seen in a hospital with more advanced stroke services then repatriated to a community hospital. If the community hospital is reporting on this indicator they should also include these patients in the numerator and denominator. All stroke patients should be included in the numerator and denominator if they were further managed at your hospital. 4

7 3. Proportion of all admitted stroke patients who are on a ward where stroke patients are clustered Purpose and Rationale Ideally all stroke patients should be cared for on a designated and geographically defined stroke unit for acute inpatient care and rehabilitation. In hospitals where dedicated stroke units are not available, patients should be clustered or admitted to the same section of the same ward. In this setting, staff members should have specialized knowledge of stroke management and patients should have access to early rehabilitation and other services that are provided in dedicated stroke units. Please refer to the Canadian stroke Strategy guide to the Implementation of Stroke Unit Care for additional information on the activities and components of acute inpatient and rehabilitation stroke care. Definition Numerator: Number of patients admitted to hospital with stroke who are on a ward where stroke patients are intentionally clustered and receive specialized stroke care. Include as an event for the numerator: All TIA, ischemic and hemorrhagic stroke patients admitted to hospital and admitted to a bed on a unit where stroke patients are clustered Exclude as an event for the numerator: Patients admitted to ICU, a surgical ward, general medical or neurology ward or a mixed rehab unit where there is not intentional clustering of stroke patients. Denominator: Total number of stroke patients admitted to hospital. Include as an event for the denominator: All TIA, ischemic and hemorrhagic stroke patients admitted to hospital acute inpatient or inpatient rehabilitation Exclude as an event for the denominator: All stroke and TIA patients discharged directly from the ED Collecting Data This indicator applies in acute care and inpatient rehabilitation. The name of the ward where stroke patients are clustered should be known and communicated. Performance Indicator Threshold 75% of all stroke patients admitted to inpatient rehabilitation are managed on a stroke unit for all or part of their inpatient stay 5

8 Analysis and Reporting Calculate and report count of all stroke patients who spend any part of their in-hospital stay clustered with other stroke patients as a model of care Calculate and report as a proportion of all stroke patients admitted to the inpatient setting (n, %). Limitations and Considerations This performance measure should be applied only in acute care and rehabilitation institutions where designated stroke units are not available and this would replace that indicator. This indicator data can be challenging to interpret. Care must be taken when collecting and reporting this data. There should be an intentional effort and a plan to cluster patients and to manage them using protocols and other components of stroke unit care. This plan will need to be demonstrated to the surveyors. 6

9 4. Proportion of all stroke patients who receive an initial rehabilitation assessment within 48 hours of admission Purpose and Rationale Early consultation with rehabilitation professionals contributes to reductions in complications from immobility such as joint contracture, falls, aspiration pneumonia, and deep vein thrombosis. Another key benefit of early consultation with rehabilitation professionals is early discharge planning for transition from acute care to specialized rehabilitation units or to the community. The first interprofessional assessment after admission must identify the physical, cognitive and communication complications of the stroke to help identify the likely discharge needs. Definition Numerator: Number of patients with initial assessment for stroke rehabilitation within 48 hours documented in their chart. Include as an event for the numerator: All stroke patients admitted to an acute care hospital who have documentation that an assessment was completed by at least one rehabilitation professional within 48 hours of hospital admission. Exclude as an event for the numerator: Patients who do not have documentation on their chart that a rehab assessment was completed in the first 48 hours following hospital admission Denominator: All ischemic, hemorrhagic and TIA stroke patients admitted to acute inpatient care. Include as an event for the denominator: All stroke patients admitted to an acute inpatient hospital Exclude as an event for the denominator: All patients discharged directly from the ED Collecting Data The information for this indicator should be documented on the patients chart in the nurses notes, interprofessional progress notes and in referral or consult notes and requests. A rehabilitation professional conducting an initial assessment should include at least one of: a physiatrist, physiotherapist, occupational therapist, speech language pathologist. Performance Indicator Threshold 80% of all admitted stroke patients should have an initial assessment for rehabilitation within 48 hours of hospital admission 7

10 Analysis and Reporting Calculate and report count of all stroke and TIAs receiving an initial rehab assessment within 48 hours; and as a proportion of all stroke and TIA patients (n, %) Also calculate and report mean, median and percentile (10th, 25th, 50th, 75th, 90th) door-to-first rehab assessment times in hours Limitations and Considerations Applies to assessment in acute care and also re-assessment once admitted to inpatient rehabilitation. May be difficult to obtain. Need to clarify/define what constitutes an initial rehabilitation assessment when reporting and be able to articulate this to surveyors and your colleagues. Also need to encourage better documentation that an assessment has been completed and the nature of the assessment (when, by whom, extent). 8

11 5. Percentage of inpatients with stroke that experience complications during inpatient stay: including pneumonia, venous thrombo-embolism, gastrointestinal bleed, secondary cerebral hemorrhage, pressure ulcers, urinary tract infection Purpose and Rationale All stroke patients are at risk of complications during in-hospital stay. Reduced complication rates is a measure of effectiveness of care. Definition Numerator: Total number of admissions that experience at least one complication during inpatient stay. Include as an event for the numerator: Any patient that experiences at least one of the following complications: pneumonia, venousthrombo-embolism (VTE), gastro-intestinal bleed, secondary cerebral hemorrhage, pressure ulcer, or urinary tract infection (UTI) Exclude as an event for the numerator: Patients who experience other complications only Denominator: Total number of stroke inpatient admissions. Include as an event for the denominator: All stroke inpatient admissions ischemic, hemorrhagic and TIA patients All inpatient stroke admissions who are discharged alive and those who may die in hospital Exclude as an event for the denominator: There should be no exclusions to the denominator of this indicator Collecting Data Complications listed above should occur after the patient is admitted to hospital for their stroke, and should not be considered if they are conditions that existed prior to hospital arrival for the index stroke event. There should be documentation in the physician and/or nurses' notes confirming the presence of the complication and a plan for management where appropriate. The complications included in this measure should be noted in the discharge summary. Notes that indicate 'query or 'suspected' complication should not be counted for the presence of this indicator, only confirmed cases should be counted. 9

12 Performance Indicator Threshold Rates per complication type: Pneumonia: 10%; VTE: 2%; GI Bleed: 1%; secondary ICH: 8%*; Pressure skin Ulcers: 3% Analysis and Reporting Risk adjustment is required. Factors to include are age, gender, stroke type, stroke severity, and co morbidities where possible (age and gender at a minimum) Calculate and report count of all stroke patients who have a complication in hospital; and also as a proportion of all stroke patients admitted to an inpatient setting with stroke (n, %) Report as composite and also by each complication type A complication must be a new development while in hospital and not exacerbation of a pre-existing condition or complication Report also by number patients with 1, 2 3 and >3 complications, by complication types Limitations and Considerations This indicator will count number of patients. A patient can have one or more of the complications listed. Secondary intracerebral hemorrhage refers only to cases where the hemorrhage is secondary to the patient receiving tpa, not to conversions from ischemic stroke to hemorrhagic stroke. 10

13 6. Wait time from ischemic stroke or TIA symptom onset to carotid revascularization Purpose and Rationale People with carotid territory disease have a high risk of recurrent stroke. Current strong evidence has shown that undergoing carotid endarterectomy within 2 weeks of initial stroke can significantly reduce the risk of recurrence in patients with severe stenosis. Definition Median time from stroke symptom onset to carotid endarterectomy (CEA) surgery. Numerator: Sum[LSN to CEA time (days) for all CEA stroke patients]. Include as an event for the numerator: All patients who undergo a CEA following stroke Exclude as an event for the numerator: Patients who do not undergo CEA following stroke Denominator: Number of stroke patients who undergo CEA following their stroke. Include as an event for the denominator: Include patients who undergo CEA during same admission as for the index stroke Include patients who are discharged and then readmitted for CEA after index stroke to same institution and where possible, within same region Exclude as an event for the denominator: Stroke patients who do not undergo CEA in same facility or same region** Patients who do not undergo CEA Collecting Data Data should be contained in surgical notes, physician notes and discharge summaries. Performance Indicator Threshold 90% of patients with severe carotid stenosis should undergo CEA within 2 weeks. Analysis and Reporting Should calculate mean, SD, and all percentiles (min, 5, 10, 25, 50, 75, 90, 95, 100). Median is statistic of choice for reporting on this measure. 11

14 Limitations and Considerations ** If reporting by region, then this indictor can be analyzed by the region and look at admissions and CEA across all hospitals in the region. 12

15 7. Percentage of TIA/minor stroke patients discharged directly from the ED who receive a referral for assessment in a stroke prevention clinic or equivalent before leaving hospital Purpose and Rationale Evidence clearly demonstrates that a TIA or minor stroke are unstable conditions that warn of high future risk of stroke, death or other vascular events. The risk of recurrent stroke after a transient ischemic attack is 10 20% within 90 days, and the risk is front-loaded with half of strokes in the first 2 days. Immediate initiation of secondary prevention medical therapy and carotid endarterectomy within two weeks has been shown to drastically reduce the risk of recurrent stroke. Definition Numerator: Total number of admissions to an emergency department for stroke who are discharged directly from the ED and receive a referral for a prevention follow-up. Include as an event for the numerator: All stroke and TIA patients discharged directly from the ED back to the community with a referral appointment for prevention follow-up Exclude as an event for the numerator: Patients admitted to hospital Patients without documentation or evidence that a follow-up appointment has been made for stroke prevention Denominator: Total number of stroke separations directly from the ED without an inpatient admission. Include as an event for the denominator: All stroke patients discharged directly from the ED to the community Include all stroke types ischemic, hemorrhagic and TIA Exclude as an event for the denominator: Patients admitted to an acute care hospital from the ED Patients transferred from the ED to another cute care hospital Collecting Data A copy of the referral should be included on the ED chart. See ED progress notes and physician order sheets for notations regarding a referral for secondary prevention. 13

16 Performance Indicator Threshold > 90% of all stroke and TIA patients discharge directly from the ED should have a referral for follow-up prevention services Analysis and Reporting Calculate and report count of all stroke and TIA patients with a referral for secondary prevention clinics; and as a proportion of all stroke and TIA patients discharged from the ED (n, %) Limitations and Considerations Stroke prevention clinics are not available in all jurisdictions. Where they are absent, another equivalent model of care may be in place and this should be clarified before tracking this indicator. Other models may include referrals to a neurologist or internist in their clinics or offices you will need to confirm that these are for stroke prevention services. 14

17 8. Proportion of eligible stroke and transient ischemic attack patients with atrial fibrillation prescribed anticoagulant therapy on discharge from acute care Purpose and Rationale Atrial fibrillation is a significant risk factor for stroke with 1 in 6 patients with atrial fibrillation experiencing a stroke in their lifetime. Stroke caused by atrial fibrillation is highly preventable if patients are treated with anticoagulants and monitored carefully to ensure the patient is compliant and remains within the therapeutic range of anticoagulation. Definition Numerator: Number of all stroke/tia patients with atrial fibrillation who are prescribed anticoagulant therapy on d/c from ED or inpatient acute care. Include as an event for the numerator: All ischemic stroke patients with a diagnosis of atrial fibrillation and are prescribed anticoagulants at discharge from the ED or inpatient care Exclude as an event for the numerator: Patients without atrial fibrillation who are prescribed anticoagulants Patients with atrial fibrillation who are not prescribed anticoagulants Denominator: Total number of ischemic/tia stroke patients discharged from ED or inpatient acute care with a diagnosis of atrial fibrillation as well. Include as an event for the denominator: All TIA and ischemic stroke patients admitted to the ED or inpatient care with a diagnosis of stroke and a diagnosis of atrial fibrillation Exclude as an event for the denominator: Ischemic stroke and TIA patients without a diagnosis of atrial fibrillation Collecting Data A copy of a prescription for all discharge medications should be on the patient s chart. Discharge summary note should indicate both the diagnosis of atrial fibrillation and prescribed medications at discharge. Physician order sheets may list discharge medications. Performance Indicator Threshold Threshold 75% of all stroke patients with atrial fibrillation should be discharged on an anticoagulant 15

18 Analysis and Reporting Calculate and report count of all ischemic stroke patients with atrial fibrillation who are discharged with a prescription for antithrombotic therapy; and also as a proportion of all ischemic stroke patients discharged alive from hospital (ED or inpatient) (n, %). Stratify results by stroke type (TIA and ischemic stroke) as well as reporting aggregated results Limitations and Considerations Difficult to determine eligibility for anticoagulants from administrative databases. Need to define which medication groups will be included for this measure when reporting. Common medications include warfarin (Coumadin), sometimes heparin or low molecular weight heparin. 16

19 9. Number of days from stroke onset to admission to inpatient rehabilitation Purpose and Rationale Over 60% of patients with stroke will require some form of rehabilitation. There is evidence that an interprofessional approach to rehabilitation in inpatient rehabilitation services reduces long term disability after stroke. Early access to inpatient rehabilitation has been found to further improve outcomes. Definition Numerator: Sum {Stroke patient admission date to inpatient rehab facility stroke admission data to acute care ED or inpatient}. Include as an event for the numerator: All stroke patients admitted to inpatient rehabilitation Counts should be number of days Exclude as an event for the numerator: Patients who receive outpatient rehabilitation and are not admitted to an inpatient rehabilitation bed Denominator: Total number of stroke patients admitted to inpatient rehabilitation. Include as an event for the denominator: All patients admitted from acute care to inpatient rehabilitation Exclude as an event for the denominator: Patients discharged to the community or other type of convalescent facility other than inpatient rehabilitation Collecting Data This information is recorded in the NRS for facilities that report to the CIHI National Rehabilitation Reporting System. Admission date to acute care (ED or inpatient) and transfer/admission date to inpatient rehabilitation should be in the discharge note form acute care and in the progress notes. Performance Indicator Threshold 75% of all patients discharged to inpatient rehabilitation are transferred to rehab within 10 days of stroke patient admission to acute care Analysis and Reporting Calculate and report mean, median and percentile (10th, 25th, 50th, 75th, 90th) from stroke admission date (first ED triage time or inpatient admission time) to arrival in inpatient rehab (in days) 17

20 Limitations and Considerations Should break time down to acute inpatient admission time and alternate level of care days as inpatient (or days from ready to discharge to rehab until actual discharge date). Some patients may go to another setting for a short stay before entering inpatient rehab and this should also be accounted for and defined when data presented. This is especially important to note from the perspective of an inpatient rehabilitation facility reporting on this indicator. The admission to an inpatient rehabilitation bed may occur in the same facility that provided acute stroke care or it may be in a separate stand-alone inpatient rehabilitation facility. 18

21 10. Change in functional status using a standardized measurement tool, from time of admission to an inpatient rehabilitation unit for stroke patients, to the time of discharge Purpose and Rationale Inpatient stroke rehabilitation should provide adequate intensity, duration and frequency of therapy for patients to obtain optimal benefits. Intensive rehabilitation care for both acute and sub-acute stroke survivors improves arm and leg motor recovery, walking mobility and functional stats. Definition Numerator: Sum {Discharge total functional score admission total functional score}. Include as an event for the numerator: All stroke patients admitted to inpatient rehabilitation who have both an admission and discharge functional assessment completed using a standardized tool Exclude as an event for the numerator: Patients with only an admission or discharge functional score available Denominator: Total number of stroke patients admitted to inpatient rehabilitation. Include as an event for the denominator: All stroke patients admitted to inpatient rehabilitation who have both an admission and discharge functional assessment completed using a standardized tool Exclude as an event for the denominator: Patients with only an admission or discharge functional score available Collecting Data Data should be collected from a standardized data collection tool. The most commonly used tool in Canada in inpatient rehabilitation facilities is the Functional Independence Measure (FIM). The total functional score should be used of calculations, not the sub scores. Performance Indicator Threshold 90% of patients will have an improvement by at least 20 points on the FIM from admission to discharge in inpatient rehabilitation Analysis and Reporting Based on the FIM, Calculate and report mean and median change in FIM scores. Calculating a percent-change in FIM is not generally considered a valid analysis. 19

22 Limitations and Considerations Need to define a standardized functional scale to use, and set time intervals. NRS uses the FIM scale. *Some centres use other valid tools instead of the FIM (such as the Barthel). The tool can be individualized as long as the tool is a validated assessment tool for functional status and the parameters for a clinically significant difference in scores is clearly stated. 20

23 11. Proportion of stroke patients with documentation to indicate screening for depression was performed either informally or using a formal assessment tool in the acute care or rehabilitation setting following an acute stroke event Purpose and Rationale Post-stroke depression may affect as many as 1 in every 4 individuals with a significant stroke. The stroke survivor is at greatest risk for depression within the first few months after stroke. Depression may affect the patient s ability to participate in therapy and is associated with slower recovery. Definition Numerator: Number of stroke patients with documentation to indicate screening for depression was performed either informally or using a formal assessment tool in a rehabilitation setting following an acute stroke event. Include as an event for the numerator: all stroke patients in acute inpatient care or inpatient rehabilitation with documentation that screening for depression was completed Exclude as an event for the numerator: all stroke patients without documentation that screening for depression was performed Denominator: Total number of stroke patients admitted to acute inpatient care or inpatient rehabilitation. Include as an event for the denominator: All admitted stroke patients Exclude as an event for the denominator: Patients who die in hospital while admitted to acute inpatient care for stroke Collecting Data This should be documented in the interprofessional progress notes, physician notes or on a consult form for psychology, psychiatry or possibly social work. Documentation should clearly indicate that the patient was assessed for possible depression. Performance Indicator Threshold 80% of all patients in inpatient rehabilitation have documentation of a screen for depression 21

24 Analysis and Reporting Calculate and report count of all stroke patients in the emergency department, acute inpatient setting or inpatient rehabilitation who are screened for depression; and also report as a proportion of all stroke patients admitted to each of these settings (n, %) Limitations and Considerations Should also track whether the screening was done using a standardized depression screening tool such as the HAD or Beck Depression Scale, or whether the screening was more of an informal assessment. 22

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as Stroke Service in Cerner. ACUTE STROKE CLINICAL PATHWAY QEH/HH PCH KCMH Souris Western Stewart Memorial O'Leary PATIENT ID INCLUSION CRITERIA* All patients admitted to hosptial with a suspected diagnosis of acute ischemic stroke

More information

Appendix L: HQO Year 1 Implementation Priorities

Appendix L: HQO Year 1 Implementation Priorities Appendix L: HQO Year 1 Implementation Priorities Chronic Obstructive Pulmonary Disease (Source: COPD Chairs) Non-Invasive Positive Pressure Ventilation Early Ambulation If possible, seek patient preferences

More information

ALBERTA PROVINCIAL STROKE STRATEGY (APSS)

ALBERTA PROVINCIAL STROKE STRATEGY (APSS) ALBERTA PROVINCIAL STROKE STRATEGY (APSS) Stroke Systems of Care Key Components APSS Pillar Recommendations March 28, 2007 1 The following is a summary of the key components and APSS Pillar recommendations

More information

Stroke Care First week

Stroke Care First week Stroke Care First week Florence Nightingale (1820 1910) Stroke Unit Dedicated personnel trained in stroke management Stepwise guidelines supported by explicit checklists Continuous monitoring available

More information

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from

More information

AHA/ASA Ischemic Stroke Performance Measures

AHA/ASA Ischemic Stroke Performance Measures AHA/ASA Ischemic Stroke Performance Measures 1. Venous thromboembolism prophylaxis Percentage of patients with ischemic stroke who receive venous thromboembolism prophylaxis Numerator Hospital day 0 or

More information

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services

More information

Level III Stroke Center Data Collection Requirements

Level III Stroke Center Data Collection Requirements Who? Level III Stroke Center Data Collection Requirements All LERN Level III Stroke Centers. LERN Level I and II Stroke Centers have reporting requirements to The Joint Commission or other Board approved

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

convey the clinical quality measure's title, number, owner/developer and contact

convey the clinical quality measure's title, number, owner/developer and contact CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical

More information

TORONTO STROKE FLOW INITIATIVE - Inpatient Rehabilitation Best Practice Recommendations Guide (updated January 23, 2014)

TORONTO STROKE FLOW INITIATIVE - Inpatient Rehabilitation Best Practice Recommendations Guide (updated January 23, 2014) TORONTO STROKE FLOW INITIATIVE - Inpatient Rehabilitation Best Practice Guide (updated January 23, 2014) Objective: To enhance system-wide performance and outcomes for persons with stroke in Toronto. Goals:

More information

How To Plan A Rehabilitation Program

How To Plan A Rehabilitation Program Project Plan to Rehabilitation Service Connecting and Collaborating in the Continuity of Care in Rehabilitation Presented By: Arlene Whitehead, May 31, 2011 Rehabilitation Collaborative Overview OUTLINE

More information

Stroke Rehab Across the Continuum of Care in Quinte Region

Stroke Rehab Across the Continuum of Care in Quinte Region Stroke Rehab Across the Continuum of Care in Quinte Region Adrienne Bell Smith Manager of Rehab Therapies QHC Karen Brown Manger Client Services, Hospital Access South East CCAC Disclosure of Potential

More information

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012 Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced

More information

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium October 30, 2008 Barry Libman, RHIA, CCS, CCS-P President, Barry Libman Inc. Stroke Coding Issues Outline Medical record documentation

More information

GP Round Up Introduction by Alistair Flowerdew Medical Director

GP Round Up Introduction by Alistair Flowerdew Medical Director GP Round Up Issue 55 October 2014 Contents GP Round Up Introduction by Alistair Flowerdew Medical Director... 1 Observation ward opens in Emergency Department... 2 Orthopaedic Elective Centre to open in

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Mobile Rehabilitation Team St Vincent s Style. Dr Shari Parker Rehabilitation Physician

Mobile Rehabilitation Team St Vincent s Style. Dr Shari Parker Rehabilitation Physician Mobile Rehabilitation Team St Vincent s Style Dr Shari Parker Rehabilitation Physician Drivers for Change 1. Pressure on beds, bed blocks 2. Evidence for Early Rehabilitation 3. The problem of Deconditioning

More information

JHS Stroke Program. 2016 JHS Annual Mandatory Education

JHS Stroke Program. 2016 JHS Annual Mandatory Education JHS Stroke Program 2016 JHS Annual Mandatory Education Learner Objectives At the conclusion of this module learners will be able to: State the definition of stroke Discuss the pathophysiology of stroke

More information

Best Practice Recommendations for Inpatient Stroke Care: Rationale and Evidence for Integrated Stroke Units in North Simcoe Muskoka LHIN

Best Practice Recommendations for Inpatient Stroke Care: Rationale and Evidence for Integrated Stroke Units in North Simcoe Muskoka LHIN Best Practice Recommendations for Inpatient Stroke Care: Rationale and Evidence for Integrated Stroke Units in North Simcoe Muskoka LHIN Physician Education Session May 24, 2013 Dr. Mark Bayley,, Cheryl

More information

What do these stories illustrate about ER/ALC issue?

What do these stories illustrate about ER/ALC issue? What do these stories illustrate about ER/ALC issue? Maximizing the Impact of Rehab on Provincial Priority Issues Mark Bayley, MD, FRCPC Medical Director, Neuro Rehabilitation Program, Toronto Rehab and

More information

Pathways of Care for People With Stroke in Ontario

Pathways of Care for People With Stroke in Ontario July 2012 Pathways of Care for People With Stroke in Ontario Health System Performance Overview Stroke represents a significant burden for patients, their families and the health care system. It is a leading

More information

ISSUED BY: TITLE: ISSUED BY: TITLE: President

ISSUED BY: TITLE: ISSUED BY: TITLE: President CLINICAL PRACTICE GUIDELINE PROFESSIONAL PRACTICE TITLE: Stroke Care Rehabilitation Unit DATE OF ISSUE: 2005, 05 PAGE 1 OF 7 NUMBER: CPG 20-3 SUPERCEDES: New ISSUED BY: TITLE: Chief of Medical Staff ISSUED

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

Provincial Rehabilitation Unit. Patient Handbook

Provincial Rehabilitation Unit. Patient Handbook Provincial Rehabilitation Unit Patient Handbook ONE ISLAND FUTURE ONE ISLAND HEALTH SYSTEM Welcome to Unit 7, the Provincial Rehabilitation Unit. This specialized 20 bed unit is staffed by an interdisciplinary

More information

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation

More information

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with

More information

Ischaemic stroke 85% (85 in every 100 strokes)

Ischaemic stroke 85% (85 in every 100 strokes) UNDERSTANDING STROKE DUE TO INTRACEREBRAL HAEMORRHAGE This factsheet provides information for people who have had a stroke due to an intracerebral (bleed in the brain) and for their families and carers.

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

Ontario Stroke System. Prepared by: Stroke Rehabilitation Evaluation Working Group Stroke Evaluation Advisory Committee May, 2007

Ontario Stroke System. Prepared by: Stroke Rehabilitation Evaluation Working Group Stroke Evaluation Advisory Committee May, 2007 Ontario Stroke System Stroke Rehabilitation Performance Measurement Manual Prepared by: Stroke Rehabilitation Evaluation Working Group Stroke Evaluation Advisory Committee May, 2007 Stroke Rehabilitation

More information

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7

More information

Long term care coding issues for ICD-10-CM

Long term care coding issues for ICD-10-CM Long term care coding issues for ICD-10-CM Coding Clinic, Fourth Quarter 2012 Pages: 90-98 Effective with discharges: October 1, 2012 Related Information Long Term Care Coding Issues for ICD-10-CM Coding

More information

Review of the Stroke and VTE Measure Sets

Review of the Stroke and VTE Measure Sets Review of the Stroke and VTE Measure Sets Vicky Agramonte, RN, MSN IPRO Quality Data Reporting and Improvement Project Presentation to NYS Hospitals January 29, 2013 The QIO Program CMS Leads a national

More information

Physician and other health professional services

Physician and other health professional services O n l i n e A p p e n d i x e s 4 Physician and other health professional services 4-A O n l i n e A p p e n d i x Access to physician and other health professional services 4 a1 Access to physician care

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,

More information

Rehabilitation. Care

Rehabilitation. Care Rehabilitation Care Bruyère Continuing Care is the champion of well-being for aging Canadians and those requiring Continuing Care, helping them to become and remain as healthy and independent as possible

More information

9/5/14. Objectives. Atrial Fibrillation (AF)

9/5/14. Objectives. Atrial Fibrillation (AF) Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three

More information

2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC

2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC 2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC Disclosures Lori M. Massaro, MSN,CRNP speakers bureau Genentech Kari Moore, MSN, AGACNP-BC -none 1

More information

The Quality of Stroke Care in Canada. Canadian Stroke Network

The Quality of Stroke Care in Canada. Canadian Stroke Network Canadian Stroke Network 2011 ACKNOWLEDGEMENTS was funded and authored by the Canadian Stroke Network using the database and methodology developed for the Registry of the Canadian Stroke Network. The Canadian

More information

TORONTO STROKE FLOW INITIATIVE - Outpatient Rehabilitation Best Practice Recommendations Guide (updated July 26, 2013)

TORONTO STROKE FLOW INITIATIVE - Outpatient Rehabilitation Best Practice Recommendations Guide (updated July 26, 2013) Objective: To enhance system-wide performance and outcomes for persons with stroke in Toronto. Goals: Timely access to geographically located acute stroke unit care with a dedicated interprofessional team

More information

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center Medical Management of Ischemic Stroke: An Update Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center Objectives Diagnostic evaluation and management of acute ischemic stroke. Inpatient management

More information

UNDERSTANDING YOUR STROKE Ischemic / TIA

UNDERSTANDING YOUR STROKE Ischemic / TIA UNDERSTANDING YOUR STROKE Ischemic / TIA MIND BODY SPIRIT EMOTION Stroke: Mind, Body, Spirit, Emotions What is a Stroke? A stroke is a sudden decrease in the oxygen and blood supply to part of the brain.

More information

Meaningful Use (MU) Education

Meaningful Use (MU) Education Meaningful Use (MU) Education The 2014 MU training program has been developed to ensure high quality patient outcomes in conjunction with meeting CMS regulatory requirements. The new charting and ordering

More information

Hospital-Based Sub-Acute Stroke Care and Secondary Prevention. Timothy Lukovits,, M.D.

Hospital-Based Sub-Acute Stroke Care and Secondary Prevention. Timothy Lukovits,, M.D. Hospital-Based Sub-Acute Stroke Care and Secondary Prevention Timothy Lukovits,, M.D. Volunteer group members Shalini Bansil,, MD Summit NJ Ji Chong,, MD, NYC, NY Srinath Kadimi,, M.D. Fairfield, CT Steve

More information

Is this pt s brain dysfunction due to ischemia? Onset & progression of sx; location of deficit

Is this pt s brain dysfunction due to ischemia? Onset & progression of sx; location of deficit CEREBROVASCULAR ACCIDENTS & TIA s Maggie Kelly History: Onset of symptoms exact time Previous sxs suggestive of TIA s Progression of symptoms Headache? Medications Past history of CVA, clotting events

More information

Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011

Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011 Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 TREATMENT OF ACUTE ISCHEMIC STROKE (AIS) 1. PURPOSE: This Veterans Health Administration (VHA)

More information

Get With The Guidelines - Stroke PMT Special Initiatives Tab for Ohio Coverdell Stroke Program CODING INSTRUCTIONS Effective 10-24-15

Get With The Guidelines - Stroke PMT Special Initiatives Tab for Ohio Coverdell Stroke Program CODING INSTRUCTIONS Effective 10-24-15 Get With The Guidelines - Stroke PMT Special Initiatives Tab for Ohio Coverdell Stroke Program CODING INSTRUCTIONS Effective 10-24-15 Date and time first seen by ED MD: The time entered should be the earliest

More information

America s Hospitals: Improving Quality and Safety

America s Hospitals: Improving Quality and Safety America s Hospitals: Improving Quality and Safety The Joint Commission s Annual Report 2014 Top Performer on Key Quality Measures America s Hospitals: Improving Quality and Safety The Joint Commission

More information

ACUTE STROKE PATHWAY

ACUTE STROKE PATHWAY ACUTE STROKE PATHWAY THERE IS A NEED FOR STATEWIDE STROKE SYSTEM OF CARE ALL MISSISSIPPIANS SHOULD BE ABLE TO ACCESS NEW PROTOCOLS FOR STROKE TREATMENT JOINT EFFORT WITH EMS, PHYSICIANS, HOSPITALS AND

More information

NHS Midlands and East Stroke Services Specification

NHS Midlands and East Stroke Services Specification NHS Midlands and East Stroke Services Specification Version Control Version No. Date Authors/ Editors To be reviewed by Status v1.0 01 June 2012 Tim Lawrence, Laura Dendy External Expert Advisory Group

More information

What Is an Arteriovenous Malformation (AVM)?

What Is an Arteriovenous Malformation (AVM)? What Is an Arteriovenous Malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair 1 What

More information

National Sentinel Stroke Audit Phase I (organisational audit) 2006 Phase II (clinical audit) 2006. Report for England, Wales and Northern Ireland

National Sentinel Stroke Audit Phase I (organisational audit) 2006 Phase II (clinical audit) 2006. Report for England, Wales and Northern Ireland National Sentinel Stroke Audit Phase I (organisational audit) 2006 Phase II (clinical audit) 2006 Report for England, Wales and Northern Ireland Prepared on behalf of the Intercollegiate Stroke Working

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

Service Specification Template Department of Health, updated June 2015

Service Specification Template Department of Health, updated June 2015 Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st

More information

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre GP workshop Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre Stroke: the Facts Stroke: the Facts Every 5 minutes someone in the UK has a stroke 1 in 4 men and 1 in 5 women will have a stroke

More information

Patient s Handbook. Provincial Rehabilitation Unit ONE ISLAND HEALTH SYSTEM ONE ISLAND FUTURE 11HPE41-30364

Patient s Handbook. Provincial Rehabilitation Unit ONE ISLAND HEALTH SYSTEM ONE ISLAND FUTURE 11HPE41-30364 Patient s Handbook Provincial Rehabilitation Unit ONE ISLAND FUTURE ONE ISLAND HEALTH SYSTEM 11HPE41-30364 REHABILITATION EQUIPMENT USED ON UNIT 7 During a patient s stay on Unit 7, various pieces of

More information

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,

More information

Accreditation and Certification Guidelines

Accreditation and Certification Guidelines Accreditation and Certification Guidelines MARTIN GIZZI, MD, PHD, FAHA CHAIR, NJ NEUROSCIENCE INSTITUTE AT JFK CHAIR, NORTH EAST CEREBROVASCULAR CONSORTIUM (NECC) CHAIR, STROKE ADVISORY PANEL, NJDOH MEMBER,

More information

Guidelines and Protocols

Guidelines and Protocols TITLE: HEAD TRAUMA PURPOSE: To provide guidelines for rapid, accurate assessment of the head and intracranial structures for traumatic injury and to plan and implement appropriate interventions for identified

More information

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM This report was commissioned by the NIHR HTA Programme as project number 12/78

More information

2. Background This indication of rivaroxaban had not previously been considered by the PBAC.

2. Background This indication of rivaroxaban had not previously been considered by the PBAC. PUBLIC SUMMARY DOCUMENT Product: Rivaroxaban, tablets, 15mg and 20mg, Xarelto Sponsor: Bayer Australia Ltd Date of PBAC Consideration: March 2013 1. Purpose of Application The application requested the

More information

Inpatient and Outpatient Manual Changes for 2015

Inpatient and Outpatient Manual Changes for 2015 Inpatient and Outpatient Manual Changes for 2015 Jill Daniel Project Manager Quality Measures Abstraction 15-036-AB GoToWebinar The Questions Chat Box Set your audio option Introduction to Data Dictionary

More information

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus TIRR Memorial Hermann is a nationally recognized rehabilitation hospital that returns lives interrupted by neurological illness, trauma or other debilitating conditions back to independence. Some of the

More information

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Disclosures Jeanie Luciano Genentech speakers bureau Claranne Mathiesen - none 1 Objective

More information

Cardiovascular Health & Stroke SCN Project Overview

Cardiovascular Health & Stroke SCN Project Overview Cardiovascular Health & Stroke SCN Project Overview Background The Alberta Provincial Stroke Strategy (APSS) has been successful in enhancing rural and urban stroke care across the province with improved

More information

Rehabilitation Nurses: Champions for Optimizing Stroke Rehabilitation Across the Continuum of Care

Rehabilitation Nurses: Champions for Optimizing Stroke Rehabilitation Across the Continuum of Care Rehabilitation Nurses: Champions for Optimizing Stroke Rehabilitation Across the Continuum of Care Presenters Sandra Melchiorre RN, MN, ACNP, CNN (c) Regional Stroke Acute Care Advanced Practice Nurse,

More information

The dictation system is provided for the clinical documentation of the patient record required for each hospital visit.

The dictation system is provided for the clinical documentation of the patient record required for each hospital visit. STATEMENT 3.2.14.1 STATEMENT ON DICTATION SYSTEM IN WINDSOR Undergraduate Medical Education Approved by: Clerkship & Electives Committee Date of original approval: August, 2013 Date of last review: August,

More information

Medical Assistance EHR Incentive Program MAPIR Application. 2014 EH Stage 2 Screen Shots

Medical Assistance EHR Incentive Program MAPIR Application. 2014 EH Stage 2 Screen Shots Medical Assistance HIT Initiative Medical Assistance EHR Provider Incentive Program Eligible Hospital Provider Manual v.3.1 Medical Assistance EHR Incentive Program MAPIR Application 2014 EH Stage 2 Screen

More information

Dedicated Stroke Interprofessional Rehab Team. Mixed Rehab Unit. Dedicated Rehab Unit

Dedicated Stroke Interprofessional Rehab Team. Mixed Rehab Unit. Dedicated Rehab Unit Outpatient & Community I n p a t I e n t Stroke Rehab Definition Framework Institutional Setting Inpatient Rehab in Acute Care or Rehab Hospitals* Acute Care Integrated Specialized Units Transitional Care

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

Guidelines for the Operation of Burn Centers

Guidelines for the Operation of Burn Centers C h a p t e r 1 4 Guidelines for the Operation of Burn Centers............................................................. Each year in the United States, burn injuries result in more than 500,000 hospital

More information

Inpatient Quality Reporting Program

Inpatient Quality Reporting Program Venous Thromboembolism 2015 Abstraction Guidance Questions and Answers Moderator: Candace Jackson, RN Inpatient Quality Reporting Support Contract Lead, HSAG Speakers: Denise Krusenoski, MSN, RN, CMSRN,

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Goal 1 Nursing are enter ccreditation Program Improve the accuracy of patient and resident identification. NPSG.01.01.01 Use at least two patient or resident identifiers when

More information

Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation

Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation Survey of Canadian Physicians Use of anti-thrombotic therapy for Atrial Fibrillation On the following pages are a number of questions asking about the conditions under which you would prescribe anticoagulation

More information

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatment

More information

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, postpolio syndrome, rheumatoid arthritis, lupus TIRR Memorial Hermann is a nationally recognized rehabilitation hospital that returns lives interrupted by neurological illness, trauma or other debilitating conditions back to independence. Some of the

More information

Patient and Hospital Characteristics Associated with Assessment For Rehabilitation During Hospitalization for Acute Stroke

Patient and Hospital Characteristics Associated with Assessment For Rehabilitation During Hospitalization for Acute Stroke Patient and Hospital Characteristics Associated with Assessment For Rehabilitation During Hospitalization for Acute Stroke Lead Author: Janet Prvu Bettger, ScD, FAHA Duke University ; janet.bettger@duke.edu

More information

Three-Star Composite Rating Method

Three-Star Composite Rating Method Three-Star Composite Rating Method CheckPoint uses three-star composite ratings to enable consumers to more quickly and easily interpret information about hospital quality measures. Composite ratings combine

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Effective January 1, 2015 Goal 1 Improve the accuracy of resident identification. NPSG.01.01.01 Long Term are ccreditation Program Medicare/Medicaid ertification-based Option

More information

Canadian Stroke StrategyStroke Best Practice Recommendations. Update 2010

Canadian Stroke StrategyStroke Best Practice Recommendations. Update 2010 CANADIAN STROKE STRATEGY CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE UPDATE 2010 December 8, 2010 CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE (UPDATE 2010) TABLE OF CONTENTS Acknowledgements

More information

What You Need to KnowWhen Taking Anticoagulation Medicine

What You Need to KnowWhen Taking Anticoagulation Medicine What You Need to KnowWhen Taking Anticoagulation Medicine What are anticoagulant medicines? Anticoagulant medicines are a group of medicines that inhibit blood clotting, helping to prevent blood clots.

More information

Hamilton Health Sciences Integrated Stroke Model of Care. Rhonda Whiteman, Stroke Best Practices Coordinator, Hamilton Health Sciences

Hamilton Health Sciences Integrated Stroke Model of Care. Rhonda Whiteman, Stroke Best Practices Coordinator, Hamilton Health Sciences Hamilton Health Sciences Integrated Stroke Model of Care Rhonda Whiteman, Stroke Best Practices Coordinator, Hamilton Health Sciences Integrated Stroke Model of Care Goals To provide a more comprehensive

More information

PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ANTICOAGULANT THERAPY

PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ANTICOAGULANT THERAPY PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ON ANTICOAGULANT THERAPY Prepared by: NPSA Anticoagulation Steering Group Approved by: Wirral Drug & Therapeutics Committee 14 th May 2008 Review:

More information

Preparing Your Hospital for Primary Stroke Certification Authors: Wendy J. Smith, BS, MA, RES, RCEP, RN Claranne Mathiesen, MSN, RN, CNRN

Preparing Your Hospital for Primary Stroke Certification Authors: Wendy J. Smith, BS, MA, RES, RCEP, RN Claranne Mathiesen, MSN, RN, CNRN Preparing Your Hospital for Primary Stroke Certification Authors: Wendy J. Smith, BS, MA, RES, RCEP, RN Claranne Mathiesen, MSN, RN, CNRN Disclosures Wendy J. Smith-I have no actual or potential conflict

More information

New Oral Anticoagulants. How safe are they outside the trials?

New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants

More information

Marina Richardson, M.Sc. Deb Willems, BSc.PT David Ure, OT Robert Teasell, MD FRCPC

Marina Richardson, M.Sc. Deb Willems, BSc.PT David Ure, OT Robert Teasell, MD FRCPC Assessing the Impact of Southwestern Ontario s Community Stroke Rehabilitation Teams: An Economic Analysis Presenters: Laura Allen, M.Sc. (cand.) Matthew Meyer, Ph.D (cand.) Marina Richardson, M.Sc. Deb

More information

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need

Listen to Your Heart. What Everyone Needs To Know About Atrial Fibrillation & Stroke. The S-ICD System. The protection you need Listen to Your Heart The S-ICD System What Everyone Needs To Know About Atrial Fibrillation & Stroke The protection you need without Stroke. touching Are you your at heart risk? Increase your knowledge.

More information

How many RCTs in Stroke Rehab?

How many RCTs in Stroke Rehab? Evidence Based Stroke Rehabilitation: Maximizing Recovery and Improving Outcomes Robert Teasell MD FRCPC Professor and Chair Chief Physical Medicine & Rehabilitation St. Joseph s Health Care London University

More information

Rehabilitation Compliance Risks. Agenda - Rehabilitation Compliance Risks

Rehabilitation Compliance Risks. Agenda - Rehabilitation Compliance Risks Rehabilitation Compliance Risks Christine Bachrach, Chief Compliance Officer, HealthSouth Catherine Niland, Organizational Integrity Manager, Trinity Health www.hcca-info.org 888-580-8373 Agenda - Rehabilitation

More information

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, post-polio syndrome, rheumatoid arthritis, lupus

Neurodegenerative diseases Includes multiple sclerosis, Parkinson s disease, post-polio syndrome, rheumatoid arthritis, lupus TIRR Memorial Hermann is a nationally recognized rehabilitation hospital that returns lives interrupted by neurological illness, trauma or other debilitating conditions back to independence. Some of the

More information

Good Samaritan Inpatient Rehabilitation Program

Good Samaritan Inpatient Rehabilitation Program Good Samaritan Inpatient Rehabilitation Program Living at your full potential. Welcome When people are sick or injured, our goal is their maximum recovery. We help people live to their full potential.

More information

Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers!

Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers! Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? No Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers! A/Prof Anne L. Abbott Neurologist School of Public Health

More information

All about stroke. English fact sheet. How do I recognise the signs of stroke? What is a stroke? Call StrokeLine 1800 STROKE (1800 787 653)

All about stroke. English fact sheet. How do I recognise the signs of stroke? What is a stroke? Call StrokeLine 1800 STROKE (1800 787 653) What is a? A happens when the blood supply to the brain is interrupted. Blood contains oxygen and important nutrients for your brain cells. Blood may stop moving through an artery because it is blocked

More information

New Anticoagulants and GI bleeding

New Anticoagulants and GI bleeding New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit

More information

Implementing a clustered acute stroke unit at a community hospital improves patient care

Implementing a clustered acute stroke unit at a community hospital improves patient care Implementing a clustered acute stroke unit at a community hospital improves patient care Linda Dykes, BScPT Manager, Sarnia Lambton District Stroke Centre Krista Steeves, BHScPT Physiotherapist, Bluewater

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information